Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
0.00%
)
US TECH 100
24,052.80
(
0.16%
)
Dow Jones
46,946.41
(
0.00%
)
Brent Oil
99.69
(
1.41%
)
Bitcoin
73,786.14
(
-1.41%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 129084

Wednesday, 08/01/2012 4:41:26 PM

Wednesday, August 01, 2012 4:41:26 PM

Post# of 257251
NIH study elucidates the MoA of Daclizumab in MS:

http://www.nih.gov/news/health/aug2012/ninds-01.htm

Daclizumab is being jointly developed by ABT and BIIB. It is in phase-3 for MS with an expected completion date of Mar 2014 (http://www.clinicaltrials.gov/ct2/show/NCT01064401 ).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now